Aether Biomachines: Valuation, Funding & Investors
Aether Biomachines is an American artificial intelligence company that discovers proteins with high-impact, real-world applications. At the core of its work is a Protein Function Model that can unlock new proteins for novel functions. Aether’s AI is being built on an entirely proprietary dataset developed in-house through advanced high-throughput screening and innovative assay technology.
Leadership & Board
- Current Number of Employees
- 105
- Current LinkedIn Followers
- 4,017
Latest Estimated Valuation
- Total Amount Raised
- $15M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $15M
- Latest Funding Round
- Investment
Employee Trend
Aether Biomachines had 105 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Aether Biomachines had 4,017 followers as of November 9, 2026. The number of followers increased by 29 (0.73%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 03, 2025 | Investment | $15.00M | ― |
| Oct 22, 2025 | Investment | $320.10K | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Tribe Capital | Investment |
| Natural Capital | Investment |
| Shrug Capital | Investment |
| Henkel Corporation | Investment |
| Resilience Reserve | Investment |
| 4DX Ventures | Investment |
| Unless Partners | Investment |
| Radicle Impact | Investment |
Similar Companies
A snapshot of private companies similar to Aether Biomachines, helping you discover and navigate related company profiles.
Related News and Analysis
